A

Aquitaine Science Transfert (SATT Aquitaine)

56 employees

Aquitaine Science Transfer is a Technology Transfer Office.

Investor insights

Sectors invested in

Biotechnology2
Artificial Intelligence1
Biopharma1
Therapeutics1
3D Technology1
Medical Device1
Stem Cell1
Cell therapy cGMP manufacturing1
bioreactor stem cell cultivation1
Cell Therapy1
biomimetic 3D cell culture1
Stem cell mass-production1
Cardiac Imaging1
Simulation1
Cardiac Electrophysiology1
Advanced Visualization1

Funding rounds participated in

$40M sweet spot round size

Most of their 2 investments are in rounds between $4.2M and $75M

Investor type

Incubator

Basic info

Industry

research services

Sectors

innovation
technology licensing
science transfer
Technical Support
innovation licensing
Innovation Management
technology transfer
research valuation
research

Date founded

2012

Investments made

T

TreeFrog Therapeutics raised $75M on September 13, 2021

Investors: BNP Paribas Développement, XAnge, Bristol-Myers Squibb, UK, AQUITI Gestion and Aquitaine Science Transfert (SATT Aquitaine)

i

inHEART raised $4.2M on July 2, 2020

Investors: Elaia and Aquitaine Science Transfert (SATT Aquitaine)

FAQ